药物对比
Pioglitazone vs Repaglinide
比较 Pioglitazone 与 Repaglinide 治疗2型糖尿病。TZD胰岛素增敏剂 vs 格列奈类：作用机制、副作用、心力衰竭黑框警告 vs 低血糖风险及给药剂量。
此页面暂无可用的对比维度。
临床背景
Triggered when adding a second-line oral agent to metformin in type 2 diabetes patients with insulin resistance or need for prandial glucose control.
结论
Pioglitazone suits insulin-resistant cases without heart failure, while Repaglinide offers flexible mealtime coverage at higher hypoglycemia risk.
全部药物对比